Please assess the completion status of the following clinical trial:

Trial Title: Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women with one or more of the following conditions undergoing cesarean section for obstetric indication were included:~* Maternal anemia (not less than 7 gm %).~* Macrosomic baby \>4kgs.~* Twin pregnancy and high order pregnancy.~* Polyhydramnios.~* Grand multipara.~* Previous history of atonic postpartum hemorrhage.~* Prolonged vaginal delivery.~* Emergency cesarean.~* Chorioamnionitis.~Exclusion Criteria:~* - Placenta previa.~* Patients with bleeding tendency (congenital or acquired)~* Ante-partum hemorrhage.~* Patients with no risk for uterine atony.

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- study group (Type: EXPERIMENTAL): patients at risk of uterine atony undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
- control group (Type: ACTIVE_COMPARATOR): patients at risk of uterine atony undergoing cesarean section received oxytocin only.

Based on this trial design, predict the completion outcome and termination type (if applicable).